Free Trial
→ Nvidia’s record quarter could send this new type of AI soaring (From Brownstone Research) (Ad)tc pixel
NASDAQ:MZTI

Marzetti Q4 2026 Earnings Report

Marzetti logo
$100.07 +0.58 (+0.58%)
As of 11:26 AM Eastern
This is a fair market value price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Marzetti EPS Results

Actual EPS
$1.46
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Marzetti Revenue Results

Actual Revenue
$465.03 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Marzetti Announcement Details

Quarter
Q4 2026
Date
8/25/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Marzetti Earnings Headlines

The Marzetti Company Expands New York Bakery Portfolio with New Baked Bites, Cheesy Focaccia, and Garlic Bread Loaves
September 29, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260929383945/en/the-marzetti-company-expands-new-york-bakery-portfolio-with-new-baked-bites-cheesy-focaccia-and-garlic-bread-loaves/
Marzetti (MZTI) Stock Could Be A Bargain Despite Its 42% Slump
September 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/marzetti-mzti-stock-could-bargain-071449412.html
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial
A NASDAQ-listed biotech just cleared a major regulatory milestone. The FDA has cleared its lead multiple sclerosis therapy, Lucid-MS, to enter Phase 2 clinical trials - the first time it will be tested in patients with progressive MS. Unlike treatments that suppress the immune system, Lucid-MS is designed to protect myelin, the insulating layer destroyed by the disease. In a pre-clinical mouse model, treatment led to movement recovery including walking. Independent research projects peak annual sales of up to $5 billion if Phase 2 succeeds. The stock still trades under $5 per share.tc pixel
October 6 at 1:00 AM  |  The Tomorrow Investor (Ad)
Marzetti’s (MZTI) Record Streak Hits a Wall With Outbreak and Guidance Cut
September 1, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/marzettis-mzti-record-streak-hits-a-wall-with-outbreak-and-guidance-cut-1825980/
The Dividend King Investors May Have Overlooked
August 31, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/the-dividend-king-investors-may-have-overlooked-1825367/
Margin Expansion and Acquisitions Drive The Marzetti Company’s (MZTI) Long Term Growth
August 28, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/margin-expansion-acquisitions-drive-marzetti-134642198.html
See More Marzetti Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Marzetti? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Marzetti and other key companies, straight to your email.

About Marzetti

Marzetti (NASDAQ:MZTI) is a food company known for producing and marketing salad dressings, dips, sauces, and other specialty food products. Its portfolio includes Marzetti dressings and dips, Simply Dressed refrigerated dressings, and a range of foodservice products supplied to restaurants, hospitality businesses, schools, and other institutional customers.

The company also markets complementary products such as croutons, frozen breads, fruit dips, and other bakery and frozen-food items through brands including New York Bakery and Sister Schubert’s. Its products are sold through retail grocery channels and foodservice distributors, primarily in the United States.

Marzetti traces its history to 1896, when Teresa Marzetti opened a restaurant in Columbus, Ohio. The company later became part of Lancaster Colony Corporation, which owns and operates the Marzetti brand portfolio alongside other specialty food businesses. Marzetti is therefore generally associated with Lancaster Colony rather than operating as a separately listed public company.

View Marzetti Profile
Earnings Tools